ArticleRisk analysis : an official publication of the Society for Risk Analysis2022
Vaccines and the social amplification of risk.
Article in Risk analysis : an official publication of the Society for Risk Analysis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Media Exposure and Its Association With Vaccine Attitudes, Intentions, and Hesitancy: Systematic Review.Journal of medical Internet research · 2026Pooled it
- The Social Amplification of Risk Framework Revisited: Report From an Exst Workshop on Opportunities for Conceptual Advancement.Risk analysis : an official publication of the Society for Risk Analysis · 2026Article
- Exploring Conceptualizations of COVID-19 Risk in Ideologically Distinct Online Communities: A Computational Grounded Theory Analysis.Journal of medical Internet research · 2025Article
- Negative vaccine sentiments on South African social media platforms before the COVID-19 pandemic: a mixed methods study.Frontiers in health services · 2025Article
- Using the 5C Vaccine Hesitancy Framework to Elucidate and Measure Contraceptive Acceptability in sub-Saharan Africa.Global health, science and practice · 2024Article
- A risk science perspective on vaccines.Risk analysis : an official publication of the Society for Risk Analysis · 2024Article
- The role of perceived risk on dishonest decision making during a pandemic.Risk analysis : an official publication of the Society for Risk Analysis · 2024Article
- Review
- Case report: Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case series.Frontiers in psychiatry · 2024Article
- Article
- A review of HPV and HBV vaccine hesitancy, intention, and uptake in the era of social media and COVID-19.eLife · 2023Review
- Recent trends in vaccine coverage and confidence: A cause for concern.Human vaccines & immunotherapeutics · 2023Article
- Where past meets present: Indigenous vaccine hesitancy in Saskatchewan.Medical humanities · 2023Article
- Discovery of interconnected causal drivers of COVID-19 vaccination intentions in the US using a causal Bayesian network.Scientific reports · 2023Article
- Social media for public health: Reaping the benefits, mitigating the harms.Health promotion perspectives · 2023Article
- Vaccines and the social amplification of risk.Risk analysis : an official publication of the Society for Risk Analysis · 2022Article
- The social amplification of risk framework: New perspectives.Risk analysis : an official publication of the Society for Risk Analysis · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2019, the World Health Organization (WHO) named "Vaccine Hesitancy" one of the top 10 threats to global health. Shortly afterward, the COVID-19 pandemic emerged as the world's predominant health concern. COVID-19 vaccines of several types have been developed, tested, and partially deployed with remarkable speed; vaccines are now the primary control measure and hope for a return to normalcy. However, hesitancy concerning these vaccines, along with resistance to masking and other control measures, remains a substantial obstacle. The previous waves of vaccine hesitancy that led to the WHO threat designation, together with recent COVID-19 experience, provide a window for viewing new forms of social amplification of risk (SAR). Not surprisingly, vaccines provide fertile ground for questions, anxieties, concerns, and rumors. These appear in new globalized hyperconnected communications landscapes and in the context of complex human (social, economic, and political) systems that exhibit evolving concerns about vaccines and authorities. We look at drivers, impacts, and implications for vaccine initiatives in several recent historical examples and in the current efforts with COVID-19 vaccination. Findings and insights were drawn from the Vaccine Confidence Project's decade long monitoring of media and social media and its related research efforts. The trends in vaccine confidence and resistance have implications for updating the social amplification of risk framework (SARF); in turn, SARF has practical implications for guiding efforts to alleviate vaccine hesitancy and to mitigate harms from intentional and unintentional vaccine scares.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.